Xortx Therapeutics logo

Xortx Therapeutics Share Price Today

(NASDAQ: XRTX)

Xortx Therapeutics share price is $1.01 & ₹87.84 as on 6 Mar 2025, 2.30 'hrs' IST

$1.01

-0.02

(-2.42%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Xortx Therapeutics share price in Dollar and Rupees. Guide to invest in Xortx Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Xortx Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Xortx Therapeutics share price movements

  • Today's Low: $1.01
    Today's High: $1.08

    Day's Volatility :6.59%

  • 52 Weeks Low: $0.82
    52 Weeks High: $7.00

    52 Weeks Volatility :88.29%

Xortx Therapeutics (XRTX) Returns

PeriodXortx Therapeutics IncIndex (Russel 2000)
3 Months
-11.82%
0.0%
6 Months
-57.58%
0.0%
1 Year
-83.44%
0.0%
3 Years
-25.54%
-11.6%

Xortx Therapeutics (XRTX) Key Statistics

in dollars & INR

Previous Close
$1.035
Open
$1.05
Today's High
$1.08
Today's Low
$1.0088
Market Capitalization
$4.3M
Today's Volume
$1.5K
52 Week High
$7.0
52 Week Low
$0.82
Revenue TTM
$0.0
EBITDA
$-3.3M
Earnings Per Share (EPS)
$0.12
PE Ratio
10.5
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-29.36%

How to invest in Xortx Therapeutics Stock (XRTX) from India?

It is very easy for Indian residents to invest directly in Xortx Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Xortx Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Xortx Therapeutics or XRTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Xortx Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Xortx Therapeutics shares which would translate to 0.861 fractional shares of Xortx Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Xortx Therapeutics, in just a few clicks!

Returns in Xortx Therapeutics (XRTX) for Indian investors in Rupees

The Xortx Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xortx Therapeutics investment value today

Current value as on today

₹21,123

Returns

₹78,877

(-78.88%)

Returns from Xortx Therapeutics Stock

₹83,840 (-83.84%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Xortx Therapeutics (XRTX)

19%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Xortx Therapeutics Stock from India on INDmoney has increased by 19% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Xortx Therapeutics

  • Armistice Capital, LLC

    8.22%

  • UBS Group AG

    0.54%

  • Royal Bank of Canada

    0.05%

  • Advisor Group Holdings, Inc.

    0.04%

  • Hartland & Co

    0.01%

Analyst Recommendation on Xortx Therapeutics

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 5 Wall street analysts offering stock ratings for Xortx Therapeutics(by analysts ranked 0 to 5 stars)

Based on 5 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
4
4
4
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Xortx Therapeutics Stock (XRTX)

What analysts predicted

Upside of 1104.95%

Target:

$12.17

Current:

$1.01

Insights on Xortx Therapeutics Stock (Ticker Symbol: XRTX)

  • Price Movement

    In the last 7 days, XRTX stock has moved up by 24.2%
  • XRTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 140.7%
  • XRTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 73.2%

Xortx Therapeutics Technicals Summary

Sell

Neutral

Buy

Xortx Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Xortx Therapeutics (XRTX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Xortx Therapeutics Inc logo
13.74%
-57.58%
-83.44%
-25.54%
-67.04%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Xortx Therapeutics Inc logo
10.5
10.5
NA
0.0
-0.29
-0.33
NA
2.32
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Xortx Therapeutics Inc logo
Buy
$4.3M
-67.04%
10.5
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Xortx Therapeutics

XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, pre-diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, a program to treat acute kidney injury (AKI) associated with respiratory virus infection and associated health consequences; and XRX-225, a program for treatment of type 2 diabetic nephropathy. It has a collaboration and license agreements with the Icahn School of Medicine; and a license agreement with the University of Florida Research Foundation, Inc. The company is based in Alberta Beach, Canada.
Organization
Xortx Therapeutics
Employees
2
CEO
Dr. Allen Warren Davidoff Ph.D.
Industry
Miscellaneous

Management People of Xortx Therapeutics

NameTitle
Dr. Allen Warren Davidoff Ph.D.
Founder, CEO, President & Director
Dr. Stephen Haworth M.D., MRCP
Chief Medical Officer
Dr. Stacy Evans M.B.A., M.D.
Chief Business Officer
Dr. Michael Scott Bumby D.V.M., M.B.A.
Chief Financial Officer
Nick Rigopoulos
Director of Communications
Dr. David Sans M.B.A., Ph.D.
Director of Corporate Development
Dr. David MacDonald Ph.D.
Consultant of Clinical Operations
Ms. Charlotte May
Corporate Secretary

Important FAQs about investing in XRTX Stock from India :

What is Xortx Therapeutics share price today?

Xortx Therapeutics share price today stands at $1.01, Open: $1.05 ; Previous Close: $1.03 ; High: $1.08 ; Low: $1.01 ; 52 Week High: $7.00 ; 52 Week Low: $0.82.

The stock opens at $1.05, after a previous close of $1.03. The stock reached a daily high of $1.08 and a low of $1.01, with a 52-week high of $7.00 and a 52-week low of $0.82.

Can Indians buy Xortx Therapeutics shares?

Yes, Indians can invest in the Xortx Therapeutics (XRTX) from India.

With INDmoney, you can buy Xortx Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Xortx Therapeutics at zero transaction cost.

How can I buy Xortx Therapeutics shares from India?

It is very easy to buy Xortx Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Xortx Therapeutics (XRTX) be purchased?

Yes, you can buy fractional shares of Xortx Therapeutics with INDmoney app.

What are the documents required to start investing in Xortx Therapeutics stocks?

To start investing in Xortx Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Xortx Therapeutics Stock (XRTX)?

Today’s highest price of Xortx Therapeutics (XRTX) is $1.08.

Today’s lowest price of Xortx Therapeutics (XRTX) is $1.01.

What is today's market capitalisation of Xortx Therapeutics?

Today's market capitalisation of Xortx Therapeutics XRTX is 4.3M

What is the 52 Week High and Low Range of Xortx Therapeutics Stock (XRTX)?

  • 52 Week High

    $7.00

  • 52 Week Low

    $0.82

What are the historical returns of Xortx Therapeutics (XRTX)?

  • 1 Month Returns

    13.74%

  • 3 Months Returns

    -57.58%

  • 1 Year Returns

    -83.44%

  • 5 Years Returns

    -67.04%

Who is the Chief Executive Officer (CEO) of Xortx Therapeutics ?

Dr. Allen Warren Davidoff Ph.D. is the current Chief Executive Officer (CEO) of Xortx Therapeutics.